Hebei Weimiao Biology Co., LTD 1
Location
  • Home
  • Bromazolam CAS 71368-80-4 Overview and Uses in China

Oct . 02, 2024 04:35 Back to list

Bromazolam CAS 71368-80-4 Overview and Uses in China



Bromazolam An Overview of CAS 71368-80-4 in China


Bromazolam, a compound classified within the benzodiazepine family, is recognized by its CAS number 71368-80-4. This substance has gained increasing attention in various fields, including pharmacology, drug abuse studies, and regulatory discussions. In China, as well as in many other parts of the world, bromazolam has become a subject of scrutiny due to its psychoactive properties and potential for misuse.


Chemical Structure and Properties


Bromazolam is characterized by its unique chemical structure, which includes a bromine atom attached to a benzodiazepine ring. This structural feature contributes to its pharmacological effects, which include anxiolytic (anti-anxiety), sedative, and potentially muscle-relaxant properties. The compound is typically found in a crystalline form and has a moderate solubility in organic solvents, making it amenable to various forms of formulation.


Medical Applications

While benzodiazepines are traditionally prescribed for anxiety, insomnia, and other related conditions, bromazolam has not been extensively studied in clinical settings. Its primary application lies within the realm of research rather than clinical use. Some anecdotal reports suggest that bromazolam may possess heightened anxiolytic effects compared to other benzodiazepines, but this is primarily based on user experiences rather than established scientific evidence.


Legal Status and Regulation in China


china bromazolam cas 71368-80-4

Bromazolam CAS 71368-80-4 Overview and Uses in China

In China, the legal status of bromazolam is complex. While it is not one of the commonly referenced controlled substances, there have been movements within regulatory bodies to classify certain new psychoactive substances (NPS), including bromazolam, as controlled. The Chinese government has been proactive in addressing the emergence of NPS, given their potential risks to public health. As such, the sale and distribution of bromazolam are closely monitored, and users may face legal consequences if found in possession of the substance without appropriate authorization.


Substance Abuse and Public Health Concerns


The popularity of bromazolam as a recreational drug is concerning, particularly among younger demographics. Users often report experiences of euphoria, relaxation, and altered perception. However, these effects come with a high risk of dependency and adverse side effects, including respiratory depression, memory impairment, and withdrawal symptoms. The allure of its psychoactive effects has led to an underground market where it is sold illicitly, often mixed with other substances, amplifying the risks associated with its use.


The public health system in China faces challenges in dealing with the implications of bromazolam misuse. Professionals in addiction medicine are increasingly called upon to develop effective strategies for prevention and treatment, which may include educational campaigns, harm reduction programs, and stricter regulatory measures to prevent the illicit trade of such substances.


Future Directions


As the landscape of pharmaceuticals and recreational drugs continues to evolve, further research into the pharmacokinetics and long-term effects of bromazolam is essential. Greater understanding may pave the way for potential therapeutic uses if safety and efficacy can be established. Meanwhile, the need for regulatory frameworks that adapt to the rapid emergence of new psychoactive substances remains critical.


In conclusion, bromazolam, or CAS 71368-80-4, represents a complex interaction between therapeutic potential and the challenges of substance misuse. Stakeholders in healthcare, law enforcement, and regulatory agencies must collaborate to navigate the implications of this substance effectively. As society grapples with the balance between medical innovation and public health safety, bromazolam serves as a poignant example of the ongoing dialogues surrounding drug policy in China and beyond.


Share
Next：

Latest news

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.


Hit enter to search or ESC to close
en_USEnglish
afAfrikaans sqAlbanian amAmharic arArabic hyArmenian azAzerbaijani euBasque belBelarusian bn_BDBengali bs_BABosnian bg_BGBulgarian caCatalan cebCebuano zh_CNChina zh_TWChina (Taiwan) coCorsican hrCroatian cs_CZCzech da_DKDanish nl_NLDutch eoEsperanto etEstonian fiFinnish fr_FRFrench fyFrisian gl_ESGalician ka_GEGeorgian de_DEGerman elGreek guGujarati htHaitian Creole haHausa hawHawaiian he_ILHebrew hi_INHindi hmnMiao hu_HUHungarian is_ISIcelandic igIgbo id_IDIndonesian gaIrish it_ITItalian jaJapanese jvJavanese knKannada kkKazakh kmKhmer rwRwandese ko_KRKorean ckbKurdish kyKyrgyz loLao laLatin lvLatvian lt_LTLithuanian lbLuxembourgish mk_MKMacedonian mgMalgashi ms_MYMalay ml_INMalayalam mtMaltese miMaori mrMarathi mnMongolian my_MMMyanmar ne_NPNepali nb_NONorwegian nyNorwegian orOccitan psPashto fa_IRPersian pl_PLPolish pt_PTPortuguese pa_INPunjabi ro_RORomanian ru_RURussian smSamoan gdScottish Gaelic sr_RSSerbian stSesotho snShona sdSindhi si_LKSinhala sk_SKSlovak sl_SISlovenian soSomali es_ESSpanish suSundanese swSwahili sv_SESwedish tlTagalog tgTajik ta_INTamil tt_RUTatar teTelugu thThai tr_TRTurkish tkTurkmen ukUkrainian urUrdu ug_CNUighur uz_UZUzbek viVietnamese cyWelsh xhBantu yiYiddish yoYoruba zuZulu en_USEnglish